Cykowski Lab

2098

Citations

26

h-index

About the Lab

Our Team

Dr. Cykowski is a clinical and experimental neuropathologist with an active interest in neurodegeneration. His lab seeks to clarify the relationship between neuropathology, molecular pathogenesis, and clinical findings in neurodegenerative diseases, including common dementing illness and amyotrophic lateral sclerosis (ALS). In particular, the lab has explored the role of TAR DNA-binding protein 43 kDa (TDP-43) in the pathogenesis of dementia and ALS. Dr. Cykowski's past and present research activities have received support from various organizations, including NIA/NINDS, the Houston Methodist Research Institute, Baylor College of Medicine, and the ALS association.

Our Team

Matthew D. Cykowski, MD
Chair in Pathology of Neurodegenerative Disease
Associate Professor of Pathology and Genomic Medicine, Academic Institute
Jerold B. Katz Investigator, Academic Institute


Anitha Arumanayagam, PhD (Research Associate II) - 713.441.2054 

 

Pathology News
There’s a New Strep in Town
New study highlights the complexity of human infections caused by a rapidly emerging strep subtype
Improving Vaccine Design with an AI Booster

CEPI awards $34 million to the Houston Methodist Research Institute-led consortium to use artificial intelligence for the design of vaccines to fight diseases with pandemic potential.

Omicron – Ongoing Lessons in a Pandemic

Omicron Demonstrates the Power and Necessity of Genetic Sequencing in a Pandemic

Researchers Uncover Distinct Patterns of a Common Pathology in Dementia

Known as LATE, a very common form of brain pathology affects ~40% of elderly patients. Researchers at Houston Methodist have unraveled several patterns of LATE in the brains of aging and demented patients. These patterns have distinct clinical, pathologic and genetic associations.

Fighting a Deadly Duo
Investigating therapeutics to fight deadly TB/HIV coinfections.
Houston Methodist and Purdue University Make a Breakthrough That May Result in a More Effective Tuberculosis Vaccine

A recombinant bovine adenoviral mucosal vaccine expressing mycobacterial antigen-85B generates robust protection against tuberculosis in mice

Explore the following:

Donate to Houston Methodist

With your support, Houston Methodist provides exceptional research, education, and care that is truly leading medicine.

Donate Now